Tdap vaccine not linked to preterm birth

Article

Women who receive the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) may not be at increased risk of preterm birth or other adverse birth outcomes, according to a new study in JAMA.

 

Women who receive the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) may not be at increased risk of preterm birth or other adverse birth outcomes, according to a new study in JAMA. The findings add to existing data on the safety of Tdap in pregnancy, which is recommended by the Advisory Committee on Immunization Practices.

In the retrospective, observational cohort study, administrative healthcare databases from 2 California Vaccine Safety Datalink sites were used to identify 123,494 women who had singleton pregnancies ending in a live birth between January 1, 2010 and November 15, 2012. Of them, 26,229 (21%) received Tdap during pregnancy. Cox regression was used for preterm delivery, while Poisson regression was used for the risks of small-for-gestational age (SGA), hypertensive disorders of pregnancy, and chorioamnionitis.

Overall, Tdap vaccination was not associated with increased risk of adverse birth outcomes. Incidence of preterm term delivery was 6.3% in vaccinated women and 7.8% in unvaccinated women (adjusted relative risk [RR], 1.03; 95% confidence index [CI], 0.97-1.09). Of the vaccinated women, 8.4% had SGA births, versus 8.3% of those who were unvaccinated (adjusted RR, 1.00; 95% CI, 0.96-1.06). Chorioamnionitis was diagnosed in 6.1% of vaccinated women and 5.5% of unvaccinated women (adjusted RR, 1.19; 95% CI, 1.13-1.26). In addition, administration of Tdap before 20 weeks’ gestation was not associated with development of a hypertensive disorder of pregnancy (adjusted RR, 1.09; 95% CI, 0.99-1.20).

ACOG: PROM: What have we learned since 2007?

The researchers concluded that women who received Tdap vaccination while pregnant did not have an increased risk of preterm birth, hypertensive disorder in pregnancy, or SGA birth. There was, however, a small but statistically significant risk of chorioamnionitis.


 

 

To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.

Recent Videos
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
raanan meyer, md
The impact of smoking cessation on pregnancy outcomes | Image Credit: rwjmg.rwjms.rutgers.edu
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit: cedars-sinai.org
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.